Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Apr 27;82(10):1717–1723. doi: 10.1054/bjoc.2000.1113

Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion

T Kanai 1, M Watanabe 1, A Hayashi 2, A Nakazawa 2, T Yajima 2, A Okazawa 2, M Yamazaki 2, H Ishii 2, T Hibi 1,2
PMCID: PMC2374515  PMID: 10817509

Abstract

To assess the role of interleukin-4 (IL-4) and interleukin-13 (IL-13) in colon cancer cell–cell adhesion, we investigated the effect of both cytokines in human colon cancer cell line, colo205 cell–cell adhesion. IL-4 receptor was expressed on the cell surface of colo205, and recombinant IL-4 inhibited colo205 cell–cell adhesion in a dose-dependent fashion without inhibiting cell proliferation. Flow cytometric analysis revealed that monoclonal antibodies (mAbs) directed against E-cadherin and carcinoembryonic antigen (CEA) inhibited colo205 cell–cell adhesion and IL-4 significantly inhibited the expression of E-cadherin and CEA. IL-13 also inhibited colo205 cell–cell adhesion. These results indicated that IL-4 and IL-13 inhibited colon cancer cell–cell adhesion by down-regulation of E-cadherin and CEA molecules. We then investigated the expression of both cytokines from freshly isolated colon cancer tumour-infiltrating lymphocytes (TILs). With reverse transcription-polymerase chain reaction and flow cytometric analysis, we demonstrated that colon TILs expressed IL-4 and IL-13 mRNA and protein. These results suggest that Th 2 type cytokines IL-4 and IL-13 locally-produced from TILs may regulate colon cancer adhesion by down-regulation of adhesion molecules. © 2000 Cancer Research Campaign

Keywords: IL-4, IL-13, colon cancer, cell adhesion

Full Text

The Full Text of this article is available as a PDF (241.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barth R. J., Jr, Camp B. J., Martuscello T. A., Dain B. J., Memoli V. A. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Cancer. 1996 Sep 15;78(6):1168–1178. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1168::AID-CNCR2>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  2. Benchimol S., Fuks A., Jothy S., Beauchemin N., Shirota K., Stanners C. P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989 Apr 21;57(2):327–334. doi: 10.1016/0092-8674(89)90970-7. [DOI] [PubMed] [Google Scholar]
  3. Boyer B., Dufour S., Thiery J. P. E-cadherin expression during the acidic FGF-induced dispersion of a rat bladder carcinoma cell line. Exp Cell Res. 1992 Aug;201(2):347–357. doi: 10.1016/0014-4827(92)90283-e. [DOI] [PubMed] [Google Scholar]
  4. Carlon C. A., Fabris G., Arslan-Pagnini C., Pluchinotta A. M., Chinelli E., Carniato S. Prognostic correlations of operable carcinoma of the rectum. Dis Colon Rectum. 1985 Jan;28(1):47–50. doi: 10.1007/BF02553907. [DOI] [PubMed] [Google Scholar]
  5. Di Giorgio A., Botti C., Tocchi A., Mingazzini P., Flammia M. The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int Surg. 1992 Oct-Dec;77(4):256–260. [PubMed] [Google Scholar]
  6. Fanslow W. C., Spriggs M. K., Rauch C. T., Clifford K. N., Macduff B. M., Ziegler S. F., Schooley K. A., Mohler K. M., March C. J., Armitage R. J. Identification of a distinct low-affinity receptor for human interleukin-4 on pre-B cells. Blood. 1993 Jun 1;81(11):2998–3005. [PubMed] [Google Scholar]
  7. Hom S. S., Rosenberg S. A., Topalian S. L. Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion. Cancer Immunol Immunother. 1993;36(1):1–8. doi: 10.1007/BF01789124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hoon D. S., Banez M., Okun E., Morton D. L., Irie R. F. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor. Cancer Res. 1991 Apr 15;51(8):2002–2008. [PubMed] [Google Scholar]
  9. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods. 1993 Feb 26;159(1-2):197–207. doi: 10.1016/0022-1759(93)90158-4. [DOI] [PubMed] [Google Scholar]
  10. Kanai T., Hibi T., Hayashi A., Takashima J., Shiozawa M., Aiso S., Toda K., Iwao Y., Watanabe M., Tsuchiya M. Carcinoembryonic antigen mediates in vitro cell aggregation induced by interferon-gamma in a human colon cancer cell line: requirement for active metabolism and intact cytoskeleton. Cancer Lett. 1993 Jul 30;71(1-3):109–117. doi: 10.1016/0304-3835(93)90105-i. [DOI] [PubMed] [Google Scholar]
  11. Kobayashi M., Kobayashi H., Pollard R. B., Suzuki F. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol. 1998 Jun 15;160(12):5869–5873. [PubMed] [Google Scholar]
  12. Lahm H., Schnyder B., Wyniger J., Borbenyi Z., Yilmaz A., Car B. D., Fischer J. R., Givel J. C., Ryffel B. Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int J Cancer. 1994 Nov 1;59(3):440–447. doi: 10.1002/ijc.2910590325. [DOI] [PubMed] [Google Scholar]
  13. Morisaki T., Yuzuki D. H., Lin R. T., Foshag L. J., Morton D. L., Hoon D. S. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4. Cancer Res. 1992 Nov 1;52(21):6059–6065. [PubMed] [Google Scholar]
  14. Murray D., Hreno A., Dutton J., Hampson L. G. Prognosis in colon cancer: a pathologic reassessment. Arch Surg. 1975 Aug;110(8):908–913. doi: 10.1001/archsurg.1975.01360140052011. [DOI] [PubMed] [Google Scholar]
  15. Obiri N. I., Hillman G. G., Haas G. P., Sud S., Puri R. K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest. 1993 Jan;91(1):88–93. doi: 10.1172/JCI116205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Obiri N. I., Husain S. R., Debinski W., Puri R. K. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. Clin Cancer Res. 1996 Oct;2(10):1743–1749. [PubMed] [Google Scholar]
  17. Semple T. U., Quinn L. A., Woods L. K., Moore G. E. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res. 1978 May;38(5):1345–1355. [PubMed] [Google Scholar]
  18. Tamm I., Cardinale I., Kikuchi T., Krueger J. G. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4338–4342. doi: 10.1073/pnas.91.10.4338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tamm I., Kikuchi T., Cardinale I., Krueger J. G. Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3329–3333. doi: 10.1073/pnas.91.8.3329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yoo Y. K., Heo D. S., Hata K., Van Thiel D. H., Whiteside T. L. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology. 1990 Feb;98(2):259–268. [PubMed] [Google Scholar]
  21. Zurawski G., de Vries J. E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 1994 Jan;15(1):19–26. doi: 10.1016/0167-5699(94)90021-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES